Stay updated on CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial
Sign up to get notified when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.

Latest updates to the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe PubMed publications section now states that publications are automatically filled in from PubMed, replacing the previous wording that publications come from PubMed and are automatically created by ClinicalTrials.gov. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the site-wide notice about potential delays in updates due to government funding, which related to site operations rather than the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedNo significant changes detected on the page; any visible differences appear to be minor UI or formatting updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedUpdate: page now includes a government-operating-status notice and indicates version 3.2.0; previous version 3.1.0 was removed.SummaryDifference2%

- Check69 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%

- Check84 days agoChange DetectedMinor update: version upgraded from v3.0.1 to v3.0.2. The 'Back to Top' control was removed. No changes to core content, pricing, stock, or time-related information.SummaryDifference0.1%

Stay in the know with updates to CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.